Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031118
Filing Date
2019-08-09
Accepted
2019-08-09 12:26:22
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20190630.htm 10-Q 1780724
2 EX-10.1 apvo-ex101_204.htm EX-10.1 22920
3 EX-31.1 apvo-ex311_46.htm EX-31.1 19302
4 EX-31.2 apvo-ex312_47.htm EX-31.2 19476
5 EX-32.1 apvo-ex321_44.htm EX-32.1 10290
6 EX-32.2 apvo-ex322_45.htm EX-32.2 10397
  Complete submission text file 0001564590-19-031118.txt   5351841

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT apvo-20190630.xml EX-101.INS 862301
8 XBRL TAXONOMY EXTENSION SCHEMA apvo-20190630.xsd EX-101.SCH 50600
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20190630_cal.xml EX-101.CAL 41265
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20190630_def.xml EX-101.DEF 153592
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20190630_lab.xml EX-101.LAB 375249
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20190630_pre.xml EX-101.PRE 275256
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 191012130
SIC: 2834 Pharmaceutical Preparations